Teleflex Inc
NYSE:TFX
Intrinsic Value
Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. [ Read More ]
The intrinsic value of one TFX stock under the Base Case scenario is 270.31 USD. Compared to the current market price of 211.17 USD, Teleflex Inc is Undervalued by 22%.
Valuation Backtest
Teleflex Inc
Run backtest to discover the historical profit from buying and selling TFX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Teleflex Inc
Current Assets | 1.4B |
Cash & Short-Term Investments | 222.8m |
Receivables | 443.5m |
Other Current Assets | 741.1m |
Non-Current Assets | 6.1B |
PP&E | 603.4m |
Intangibles | 5.4B |
Other Non-Current Assets | 105.7m |
Current Liabilities | 606.7m |
Accounts Payable | 132.2m |
Accrued Liabilities | 318.5m |
Other Current Liabilities | 156m |
Non-Current Liabilities | 2.5B |
Long-Term Debt | 1.7B |
Other Non-Current Liabilities | 757.2m |
Earnings Waterfall
Teleflex Inc
Revenue
|
3B
USD
|
Cost of Revenue
|
-1.3B
USD
|
Gross Profit
|
1.6B
USD
|
Operating Expenses
|
-1.1B
USD
|
Operating Income
|
562.7m
USD
|
Other Expenses
|
-206.4m
USD
|
Net Income
|
356.3m
USD
|
Free Cash Flow Analysis
Teleflex Inc
TFX Profitability Score
Profitability Due Diligence
Teleflex Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Teleflex Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
TFX Solvency Score
Solvency Due Diligence
Teleflex Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Score
Teleflex Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TFX Price Targets Summary
Teleflex Inc
According to Wall Street analysts, the average 1-year price target for TFX is 269.79 USD with a low forecast of 242.4 USD and a high forecast of 299.25 USD.
Ownership
TFX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
TFX Price
Teleflex Inc
Average Annual Return | 0.06% |
Standard Deviation of Annual Returns | 26.9% |
Max Drawdown | -59% |
Market Capitalization | 9.9B USD |
Shares Outstanding | 47 301 000 |
Percentage of Shares Shorted | 2.99% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company is headquartered in Wayne, Pennsylvania and currently employs 14,000 full-time employees. The firm primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The firm operates through four segments: Americas, Europe, the Middle East and Africa (EMEA), Asia Pacific (Asia) and Original Equipment Manufacturer and Development Services (OEM). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, conductors, sheath/dilator introducers, specialized sutures and performance fibers, bioabsorbable sutures, yarns and resins.
Contact
IPO
Employees
Officers
The intrinsic value of one TFX stock under the Base Case scenario is 270.31 USD.
Compared to the current market price of 211.17 USD, Teleflex Inc is Undervalued by 22%.